ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109834 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109834; 2) Community: the network communities that were significantly associated with the response to NSC 109834; 3) Molecule: the relationships between components within communities and NSC 109834; 4) MDR: the compounds that were significantly associated with the NSC 109834.

NSC Compound Enrichment Correlation
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00174331675630443 0.37018943
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00174331675630443 0.53557301
NSC 405029 Null 0.00174331675630443 0.35156796
NSC 665564 Null 0.00174331675630443 0.38460719
NSC 720447 Null 0.00174331675630443 -0.33130639
NSC 740 Methotrexate 0.00174331675630443 0.47714118
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.00265144454581183 0.21518865
NSC 655072 Null 0.00265144454581183 0.28405374
NSC 681636 Camptothecin Derivative 0.00265144454581183 0.28169456
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.00265144454581183 0.28632288
Total:68  Current:6    [First] [Prev] [Next] [Last]